(exhale away from the device), although there were somewhat fewer errors in Australia than Jordan (16% vs 0% in step 3, P ‫؍‬ .007, and 20% vs 0% in step 4, P ‫؍‬ .003 via chi-square test). With Turbuhaler there were significant differences between the pharmacists from Australia and Jordan, mainly in step 2 (hold the device upright while loading, 45% vs 2% correct, P < .001). Few of the patients had received inhaler-technique education in the previous year. The patients made errors similar to those of the pharmacists in individual steps with Diskus and Turbuhaler. The essential steps with Diskus were performed correctly more often by the Jordanian patients, and with Turbuhaler by the Australian patients. CONCLUSIONS: Despite differences in Jordan's and Australia's health systems, pharmacists from both Australia and Jordan had difficulty with the same Diskus and Turbuhaler steps. In both countries, the errors made by the asthma patients were similar to those made by the pharmacists.
Introduction
Asthma has no cure; however, with appropriate management, control of the disease can be achieved. 1 The inflammatory changes of asthma are primarily found locally in the airways, so it is logical to use the inhalation route for treatment. Currently, several types of inhaler are used to deliver asthma controller medications, primarily pressurized metered-dose inhaler and dry powder inhaler (eg, Diskus [GlaxoSmithKline] and Turbuhaler [AstraZeneca] ). Although these inhalers were pioneering in their designs, 2 their use is not straightforward. As with pressurized metered-dose inhaler, both Diskus and Turbuhaler require a series of maneuvers in a specific order to deliver drug into the airways. 3, 4 Judging by the many studies that have shown poor skills with the individual steps required for inhaler use, [5] [6] [7] [8] [9] [10] [11] it appears that the importance of correctly following the steps has often not been given appropriate attention by patients or healthcare professionals. Suboptimal inhaler technique is associated with increased asthma instability, 12 and because of perceived lack of effectiveness of the medication, to poor medication adherence, 13, 14 which can lead to doctors prescribing higher doses of controller medication, leading to adverse effects and higher costs. 15, 16 In many countries, pharmacists are responsible for the physical supply of medications to the patient and hence pharmacists are the last healthcare professionals the patients see before they go home to use their inhalers. Pharmacists can make use of this opportunity by assessing and educating patients on inhaler technique, both initially and at subsequent dispensing. However, many pharmacists do not correctly demonstrate the steps and hence are not skilled in educating their patients on inhaler technique. 10, 17 Incorrect demonstration of the steps by a pharmacist may be the source of incorrect inhaler technique by patients. Healthcare systems and health-professional education differ around the globe. To our knowledge, no previous study has compared the inhaler steps performed incorrectly by pharmacists and by patients, nor has there been a comparison of inhaler-technique skills among pharmacists and patients from different cultural backgrounds and healthcare systems. We compared Diskus and Turbuhaler inhaler technique among pharmacists and asthma patients in Jordan and Australia, to identify the steps that are most problematic.
Methods
This study was performed at the Applied Science Private University, Amman, Jordan, and University of Sydney, Sydney, Australia, and approved by the respective ethics committees.
Study Design
We report the individual inhaler-technique steps that were performed correctly/incorrectly by pharmacists and asthma patients in a cross-sectional study in Jordan in 2009, and in Australia in 2004, during baseline assessment in an inhaler-technique intervention study. We previously reported the proportion of Australian pharmacists and patients with correct technique, 4 and their inhaler-technique scores. 9 The methods of both studies are given below. The Australia data used in the present comparisons were from the baseline assessment of pharmacists and patients during a 6-month single-blind cluster randomized study of inhaler-technique education. 4, 9 To maintain blinding, and with the consent of the ethics committee, the pharmacists and patients were advised that the study was about ways to improve asthma management.
Inhaler-Technique Assessment
Based on published Diskus and Turbuhaler inhalertechnique steps checklists (Table 1) , and without receiving any inhaler-technique education immediately before the study, pharmacists and patients in Jordan and Australia underwent Diskus and Turbuhaler inhaler-technique assessment. 4, [8] [9] [10] 18 Both the Diskus and Turbuhaler checklists comprise 9 steps, of which 3 steps and 4 steps, respectively, are essential (see Table 1 ). GlaxoSmithKline provided placebo Diskus inhalers, and AstraZeneca provided placebo Turbuhaler inhalers.
Pharmacists in Jordan
We randomly selected and invited community pharmacists in Amman, Jordan, to participate in a study that involved attending a 3-hour educational workshop on asthma 
Asthma Patients in Jordan
We invited patients with asthma as they were leaving an out-patient clinic in Amman with a Diskus or Turbuhaler prescription. With placebo inhalers, one trained pharmacist assessed their Diskus or Turbuhaler technique. The inclusion criteria were: age Ն 14 years, doctor-diagnosed asthma, and using inhaled corticosteroids via Diskus or Turbuhaler at the same dose for at least one month. We excluded patients who did not self-administer their medication, did not speak or understand Arabic, or were involved in another clinical study.
Pharmacists in Australia
The inclusion criteria were: practicing at a pharmacy in the Sydney metropolitan area, with at least one pharmacist assistant present at all times, and not involved in any other clinical study. We excluded pharmacists who were not able to attend the 3-hour study workshop or to commit to the 6-month follow-up study. We assessed the pharmacists on their Diskus and Turbuhaler technique at the beginning of the workshop. After this baseline assessment we randomized the pharmacists to receive one of two workshops. The control group were trained to assess asthma control and to teach patients how to measure and monitor peak flow. The intervention group received that same education plus assessment of and education about Diskus and Turbuhaler technique. All the intervention-group pharmacists were able to demonstrate correct technique of both inhalers before they commenced recruiting patients. The strategy used to educate pharmacists about inhaler technique was previously evaluated for its efficacy and was reported elsewhere. 8 
Asthma Patients in Australia
Participating pharmacists recruited asthma patients who came to their community pharmacies with a prescription for Diskus or Turbuhaler. The inclusion criteria were: age Ն 14 years, doctor-diagnosed asthma, and using inhaled corticosteroids via Diskus or Turbuhaler at the same dose for at least one month. We excluded patients who did not self-administer their medication, did not speak or understand English, were not able to return for all visits, or were involved in another clinical study. One pharmacist researcher (IAB) assessed all the patients recruited by the control-group pharmacists. The intervention-group pharmacists assessed their own patients. As previously reported, the accuracy of inhaler-technique assessment by the intervention-group pharmacists was independently validated by one researcher (IAB). 9 
Data Analysis
Data were analyzed with statistics software (SPSS 17, SPSS, Chicago, Illinois). All the analyses are of assess- 
Results

Pharmacists' Demographics and Inhaler-Technique Education
In Jordan, 120 pharmacists were approached, and 73 agreed to attend the workshop, but 31 of those declined to demonstrate inhaler technique, leaving a sample size of 42 pharmacists. In Australia, 120 pharmacists were approached, and 31 attended the workshop, during which their inhaler technique was assessed. 10 Table 2 shows the pharmacists' demographic data, and Table 3 describes their inhaler education. There were no significant differences in sex, age, or years in community pharmacy practice. The mean reported time since previous inhaler device education was shorter among the Australian pharmacists, and a significantly higher proportion of the Australian pharmacists had received previous education on Diskus and Turbuhaler technique from manufacturer representatives. Figure 1 shows the percentages of pharmacists who correctly demonstrated the steps. The most frequent errors were failing to exhale fully (step 3), not exhaling away from the mouthpiece before (step 4) or after inhalation (step 8), and not holding the breath following inhalation (step 7). Most of the pharmacists from both countries did not correctly perform steps 7 or 8. Although more Australian than Jordanian pharmacists correctly demonstrated steps 3 (P ϭ .007) and 4 (P ϭ .003), the proportion who correctly demonstrated these steps was low in both countries (see Fig. 1 ). Significantly more Jordanian pharmacists correctly performed step 5 (mouthpiece between teeth and lips) (P ϭ .007), but over 80% of pharmacists from both countries performed this step correctly (see Fig. 1 ). Eighty-four percent of the Australian pharmacists correctly performed the 3 essential Diskus steps (steps 1, 2, and 6), compared to 64% of the Jordanian pharmacists, but that difference was not significant (P ϭ .064 via chi-square test).
Pharmacists' Diskus Performance
Pharmacists' Turbuhaler Performance
A high proportion of pharmacists from both countries made errors on steps in the Turbuhaler checklist (Fig. 2 ). There were significant differences between the Australian and Jordanian pharmacists. Almost none of the Jordanian pharmacists correctly performed step 2 (keep inhaler upright), step 4 (exhale fully), or step 5 (exhale away from mouthpiece), compared to 45% (P Ͻ .001), 26% (P ϭ .001), and 19% (P ϭ .003), respectively, among the Australian pharmacists. Many pharmacists from both countries also made errors in step 8 (hold breath) and step 9 (exhale away from mouthpiece), but the differences between countries were not significant (see Fig. 2 ). None of the Jordanian pharmacists correctly performed all 4 essential Turbuhaler steps (1, 2, 3, and 7), compared to 35% of the Australian pharmacists (P ϭ .002). 
Patients' Demographics and Inhaler-Technique Education
In Jordan, 60 Diskus and 60 Turbuhaler patients were approached, and 51 and 40, respectively, agreed to participate. In Australia, 53 Diskus patients and 42 Turbuhaler patients participated, but the number of patients approached is not known. There were no significant differences in age or sex of the Australian and Jordanian groups ( Table 4 ). The Australian patients had been using their Diskus controller medication for significantly shorter than the Jordanian patients.
There were significant differences between the Jordanian and Australian patients in the sources of inhaler-technique education (Table 5) . Significantly more Australian patients had received education from a general practitioner or pharmacist, whereas significantly more Jordanian patients were educated by a specialist or at a hospital. The proportion of patients who reported that they had taught themselves how to use the inhaler from the product information was low in both countries.
Patients' Diskus Performance
The pattern of patient errors with Diskus ( Fig. 3 ) was similar to that for pharmacists. The most problematic steps for patients from both countries were steps 3, 4, 7, and 8, although more Australian patients correctly performed step 3 (P ϭ .002), step 4 (P Ͻ .001), and step 7 (P ϭ .002), and more Jordanian patients correctly performed step 5 (P ϭ .01) and step 9 (P ϭ .004). Significantly more Jordanian patients than Australian patients performed the essential Diskus steps correctly (80% vs 57%, P ϭ .009).
Patients' Turbuhaler Performance
The majority of patients from both countries incorrectly performed step 2 (keep inhaler upright), and a high proportion had errors in steps 4, 5, and 8 (Fig. 4) . Although few patients from either country correctly performed steps 4 and 5, the rates were somewhat higher among the Australian patients (step 4, P ϭ .002; step 5, P Ͻ .001). None of the Jordanian patients correctly performed the essential Turbuhaler steps, compared to 29% of the Australian patients (P Ͻ .001).
Discussion
Despite differences in the healthcare systems and health education between Jordan and Australia, certain of the Diskus and Turbuhaler steps were problematic in both countries. There were similar rates of error in Jordan and Australia, and the rates were similar between the patients and pharmacists. This suggests that these problematic steps are device-specific and not a result of cultural or healtheducation backgrounds. In addition, the fact that there were similar patterns of incorrect technique in both pharmacists and patients in both countries suggests that incorrect inhaler technique among pharmacists might contribute to similar problems in patients. Hence, regardless of the medical or national background, the inhaler-technique education of health professionals needs to be actively addressed before we can expect patient education to be effective.
These results are probably not due to differences in delivery of the inhalers between Jordan and Australia. In both countries a doctor's prescription is needed to obtain Diskus or Turbuhaler, so patients from both countries may receive inhaler-technique education from doctors and/or pharmacists. The inhaler use instructions in the product leaflets are standardized in both countries.
However, there were important differences between Jordan and Australia in the sources of patient education. Significantly more Jordanian patients reported learning inhaler technique at hospitals or from specialists, whereas the Australian patients reported the most education from general practitioners and pharmacists. While these differences may reflect the different sites of patient-recruitment (hospital out-patient clinic in Jordan, community pharmacies in Australia), they may also reflect differences in the health systems for asthma care between the 2 countries. Patients with asthma in Jordan have ready access to community or hospital specialists, whereas in Australia, asthma is largely managed by general practitioners, and only a small proportion of patients visit a specialist. 19 From the present results, pharmacists seem to have a more active role in patient inhaler-technique education in Australia than in Jordan.
Although similar steps were problematic in both populations, the Australian pharmacists generally demonstrated better technique. As a faculty member in both Jordan and Australia, one of us (IAB) has observed a greater emphasis on teaching inhaler device use to undergraduate pharmacy students in Australia (at the University of Sydney) than in Jordan (at the Applied Science Private University). This may have contributed to the observed differences in pharmacist technique, although the pharmacists also came from other universities. While pharmaceutical industry representatives are important in both countries, they had a much greater role in pharmacist education in Australia than in Jordan, which may have contributed to better inhaler technique among the Australian pharmacists; this highlights the importance of pharmaceutical industry representatives correctly demonstrating inhaler use. 10 One of the strengths of this study was that we used the same checklists with patients and pharmacists, in both Jordan and Australia. Many studies have assessed patients' and pharmacists' inhaler technique, but the large differences in the proportions of incorrect inhaler technique reported from various countries could have been due to the variety of checklists used in those studies. [20] [21] [22] For example, previous studies have reported that Diskus technique was correctly performed by 13% (n ϭ 54) of Diskus users in Australia, 10 and by 93% (n ϭ 103) of Diskus users in Jordan. 23 However, that difference is not surprising, given that Basheti et al 10 used a 9-step checklist, whereas Khassawneh et al 23 used a 3-step checklist. The fewer steps in a checklist, the higher the probability that a patient will be classified as having correct technique.
We followed strict process measures in the present study to maintain consistent inhaler-technique evaluation over time and between countries. We invested detailed attention to the study design to ensure good inter-rater reliability (agreement between the scores given by different assessors for the same subject), which can be a cause of inaccuracy in this type of assessment. Observer bias was minimized with common training of the observers, followed by assessment, and use of a checklist that precisely lists detailed steps. 24, 25 Limitations to this study include the above-mentioned differences in patient recruitment, the fact that patients were not randomly selected, and in the relationship between pharmacists and patients. In Australia, the participating pharmacists recruited customers to whom they might have previously provided education in the pharmacy, whereas in Jordan the patients were recruited from established asthma clinics by one pharmacist researcher, so there was no professional relationship between the patients and the participating pharmacists. However, we do not think the different settings between the 2 countries affect the generalizability of the results. Another limitation is that the studies were not conducted at the same time, and we cannot exclude the possibility that this may have affected our results.
Although the problematic steps were similar in the 2 populations, the Australian pharmacists demonstrated better technique in the essential steps than did the Jordanian pharmacists (Diskus 64% in Jordan vs 84% in Australia, Turbuhaler 0% in Jordan vs 35% in Australia). The fact that many pharmacists from Jordan refused to demonstrate technique may suggest that poor technique was an even greater problem than we observed. Further, more Australian patients than Jordanian patients reported receiving inhaler-technique education from their pharmacists, so this study underlines the necessity to provide inhaler-technique education not only to patients, but also to all people likely to teach inhaler technique to patients: specialists, general practitioners, pharmacists, and nurses, depending on the national health organization. We previously reported methods that are effective in educating pharmacists or patients on correct inhaler technique. 4, 10, 11 There was considerable variation in the accuracy of performance of individual inhaler-technique steps. One of the most common problems with Turbuhaler was failure to hold it upright while rotating the base, a step that is essential for loading the full dose (step 2 correctly performed by 31% in Australia vs 0% in Jordan). Other studies have reported that step 2 was performed correctly by 69% 6 to 88% 5 of patients. Ekedahl 26 reported that even after one year of an open study aimed at correcting Turbuhaler technique by demonstration, many patients (33%) did not hold the Turbuhaler upright while loading the device. Turbuhaler loading was correctly performed less often than was Diskus loading (Diskus 91% vs Turbuhaler 31% in Australia, and Diskus 100% vs Turbuhaler 0% in Jordan), which supports the findings of previous studies. 6, 27 Hence, healthcare professionals should pay more attention when assessing and educating patients on the Turbuhaler loading maneuver. Since the optimal biomechanical position of the forearm for supination/pronation (the maneuver required for step 3) may contribute to the Turbuhaler being held at an angle during loading, we teach Turbuhaler users to place the base of the Turbuhaler on a flat surface for the loading step, as a visual mnemonic to ensure that it is upright.
Few patients held their breath after using Diskus (Australia 36%, Jordan 10%) or Turbuhaler (Australia 24%, Jordan 10%). Previous studies have found wide ranges in the proportions of patients who do this step correctly with Diskus (47-94%) and Turbuhaler (53-94%). 6, 27 While many published checklists contain the breath-hold instruction, it does not appear in the manufacturer's Turbuhaler instructions.
Failure to inhale forcefully and deeply was also a problem in the patients we studied, as in the majority of previous studies. 24, 27 Kamps reported that this step is the most problematic with asthmatic children. 28 Our results on the pharmacists' inhaler technique were similar to those reported in other studies of Diskus and Turbuhaler 17, 29, 30 ; however, the very low proportion of pharmacists who demonstrated correct performance of individual steps in the study by Chopra and Oprescu might have been partly due to the fact that they combined items into 6-point checklists. 30 
Conclusions
There were similar Diskus and Turbuhaler technique problems among pharmacists and patients in Jordan and Australia, despite markedly different health systems and inhaler education between the 2 countries. Awareness of the most problematic steps may help educators concentrate their efforts on these steps during inhaler education. The finding of consistent problems with certain steps should prompt the manufacturers to field test early in the development of new inhalers, to ensure that future inhalers will be easier to teach and use.
